Such a scenario likely occurs in the case of breast cancer cells treated with NSAIDs because, in such conditions, increases in the expressions of AMPK and mTOR were observed, especially in the cases of the treatments of the cells with indomethacin, diclofenac, and sulindac. Here, MTOR is linked to breast cancer.